Pancreatic Cancer Research

ResearcherJapan Society for the Promotion of ScienceActive in the last 2 years

Mina Fukasawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-4580-8353; OpenAlex author ID A5007426414. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 7 papers

Papers 9

  1. Successful conversion surgery for patients with pancreatic cancer, positive peritoneal cytology, and liver metastasis who were treated with chemotherapy involv… Co-author DOI 10.1007/s12328-025-02175-2↗
  2. FUT2 and FUT3-specific normalization of DUPAN-2 and carbohydrate antigen 19-9 in preoperative therapy for pancreatic cancer: multicentre retrospective study (G… Co-author DOI 10.1093/bjs/znaf049↗
  3. Risk Factors for Early Liver Recurrence After Pancreatic Cancer Resection. Co-author DOI 10.1097/mpa.0000000000002441↗
  4. Gastrojejunostomy for Asymptomatic Gastric Outlet Obstruction in Pancreatic Cancer May Contribute to Early Recovery. Co-author DOI 10.21873/anticanres.17618↗
  5. Novel CTC Detection Method in Patients with Pancreatic Cancer Using High-Resolution Image Scanning. Co-author DOI 10.3390/cancers17223640↗
  6. McKeown Esophagectomy for Esophageal Cancer Following Pancreaticoduodenectomy Using a Mesenteric Approach for Pancreatic Cancer: A Case Report. Co-author DOI 10.70352/scrj.cr.25-0204↗
  7. [Conversion Surgery for Pancreatic Cancer]. First author PMID 39957218↗
  8. Evaluating staging laparoscopy indications for pancreatic cancer based on resectability classification and treatment strategies for patients with positive peri… First author DOI 10.1002/ags3.12719↗
  9. Efficacy of staging laparoscopy for resectable pancreatic cancer on imaging and the therapeutic effect of systemic chemotherapy for positive peritoneal cytolog… Co-author DOI 10.1002/jhbp.1356↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tsutomu Fujii · 9 shared papers, 2023–2025 · strength 1.94
  2. Nana Kimura · 8 shared papers, 2023–2025 · strength 1.74
  3. Katsuhisa Hirano · 6 shared papers, 2025 · strength 1.35
  4. Haruyoshi Tanaka · 4 shared papers, 2023–2025 · strength 0.83
  5. Yoshihiro Shirai · 3 shared papers, 2025 · strength 0.70
  6. Ayaka Itoh · 3 shared papers, 2023–2025 · strength 0.63
  7. Takamichi Igarashi · 2 shared papers, 2024–2025 · strength 0.45
  8. Takeshi Miwa · 2 shared papers, 2025 · strength 0.40
  9. Kenichi Hirabayashi · 2 shared papers, 2023–2024 · strength 0.39
  10. Mariko Horikawa · 1 shared paper, 2025 · strength 0.21
  11. Tomohisa Otsu · 1 shared paper, 2025 · strength 0.20
  12. Masaya Suenaga · 1 shared paper, 2025 · strength 0.20
  13. Toshio Kokuryo · 1 shared paper, 2025 · strength 0.20
  14. Junpei Yamaguchi · 1 shared paper, 2025 · strength 0.20
  15. Masaki Sunagawa · 1 shared paper, 2025 · strength 0.20
  16. Nobuhiko Nakagawa · 1 shared paper, 2025 · strength 0.20
  17. Yasuhiro Kodera · 1 shared paper, 2025 · strength 0.20
  18. Tomoki Ebata · 1 shared paper, 2025 · strength 0.20
  19. Takahiro Manabe · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.